Michael Kaseta
2017 - Aralez Pharmaceuticals
In 2017, Michael Kaseta earned a total compensation of $471K as Chief Financial Officer at Aralez Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $99,430 |
|---|---|
| Option Awards | $51,181 |
| Salary | $305,513 |
| Stock Awards | $5,925 |
| Other | $9,000 |
| Total | $471,049 |
Kaseta received $305.5K in salary, accounting for 65% of the total pay in 2017.
Kaseta also received $99.4K in non-equity incentive plan, $51.2K in option awards, $5.9K in stock awards and $9K in other compensation.
Rankings
In 2017, Michael Kaseta's compensation ranked 12,067th out of 14,666 executives tracked by ExecPay. In other words, Kaseta earned more than 17.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,067 out of 14,666 | 18th |
Division Manufacturing | 4,751 out of 5,768 | 18th |
Major group Chemicals And Allied Products | 1,731 out of 2,074 | 17th |
Industry group Drugs | 1,434 out of 1,730 | 17th |
Industry Pharmaceutical Preparations | 1,115 out of 1,329 | 16th |
Source: SEC filing on May 18, 2018.
Kaseta's colleagues
We found five more compensation records of executives who worked with Michael Kaseta at Aralez Pharmaceuticals in 2017.
2017
Adrian Adams
Aralez Pharmaceuticals
Chief Executive Officer
2017
Scott Charles
Aralez Pharmaceuticals
Chief Financial Officer
2017
Andrew Koven
Aralez Pharmaceuticals
President and Chief Business Officer
2017
James Tursi
Aralez Pharmaceuticals
Chief Medical Officer
2017
Mark Glickman
Aralez Pharmaceuticals